Utah insurer to pay enrollees to buy prescriptions from Mexico

As healthcare prices and prescription drug costs continue to soar in the United States, one insurer in Utah is taking an innovative approach to reducing costs—by offering to pay its enrollees to fill prescription medications in Mexico, The Salt Lake Tribune reported.

PEHP, a Utah-based health plan that covers 160,000 public employees and family members, has rolled out a pharmacy tourism option to some of its enrollees, which will allow them to fly to San Diego, go to Tijuana, Mexico, and take a $500 cash payout to buy their medicines there. The option applies to some patients who need certain expensive drugs for multiple sclerosis (MS), cancer and autoimmune disorders, covering about a dozen drugs, the Tribune reported.

One drug under the policy that treats MS, Avonex, costs about $6,700 for a 28-day supply in the U.S., but only about $2,200 in Tijuana.

The option was rolled out as a result of new legislation that required insurance plans of state employees to offer savings rewards to patients who choose cheaper providers.

“Why wouldn’t we pay $300 to go to San Diego, drive across to Mexico and save the system tens of thousands of dollars?” state Rep. Norman Thurston, R-Provo, who sponsored the legislation calling for incentives, told the Tribune. “If it can be done safely, we should be all over that.”

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”